Peptide Stack

Wolverine Stack

BPC-157 + TB-500 · Wolverine blend · BPC/TB stack

Named research blend of BPC-157 plus TB-500 - the default two-peptide healing stack. We already have a full guide and GLOW/KLOW (which add GHK-Cu ± KPV). This leaf is the blend SKU itself. Each component is research-only; BPC-157 is FDA Category 2. No combined clinical trial.

Not FDA-approved - research chemicalWADA (S0) - prohibited in sport at all timesContains FDA Category 2 material (BPC-157). PCAC Jul 2026 review is advisory, not a final rule

Quick answer

What it is: Named research blend of BPC-157 plus TB-500 - the default two-peptide healing stack.

Typical research dose: BPC-157 250-500 mcg/day · TB-500 2-5 mg twice weekly

Reconstitution calculator ↓Wolverine stack: evidence, legal status and safer alternatives →

Research summary, not medical advice.

Reviewed by Kymata Health Editorial Team

·Last updated: August 2026·Evidence: Low

Typical research dose

BPC-157 250-500 mcg/day · TB-500 2-5 mg twice weekly

Frequency

Daily (BPC-157) · 2× weekly (TB-500)

Half-life

Component-wise (BPC minutes IV; TB-500 hours)

Common vials

10 mg

CAS

N/A (blend)

Molecular weight

Multi-component

Use-case scores

0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.

Injury & tissue3.5/10
The default research-chem pair. Each leaf is honest separately. The mix is not a synergy RCT.

Compound card

Class: Vendor blend (BPC-157 + TB-500 7-mer)
Formula: BPC-157 + TB-500 (blend)
Status: Not FDA-approved · research use

Dose it

10 mg + 2 mL BAC water → 5 mg/mL · advertised cake. Confirm the COA, then use the blend calculator.

Open blend calculator

How it works

Wolverine is BPC-157 + TB-500 in one named stack. BPC-157 is a 15-aa gastric peptide with extensive animal repair literature and no Phase 3. TB-500 is a thymosin β-4 fragment studied for actin/cell migration. GLOW adds GHK-Cu; KLOW adds KPV. There is no combined RCT.

Source: See /blog/wolverine-stack-peptide-guide

Research Use Cases

✓Recovery stack: Low

Dosing

Phase	Dose	Frequency	Notes
Component-wise (not a single INN)	BPC-157 250–500 mcg/day + TB-500 2–5 mg 2×/week	See components	Pre-blended vials need the blend calculator so the rate-limiting peptide is not overdrawn.

Administration

Route / form

Subcutaneous

Timing

BPC often daily; TB-500 twice weekly. Can be separate vials or one blend.

Empty stomach?

No - Food timing is not critical.

Timeline

Weeks 1–4

Community reports of pain/inflammation change; not a trial endpoint.

Who it is for

Recovery stack

Low

Two research peptides. BPC-157 is FDA Category 2. This is a name, not a drug.

Reconstitution

Vial	Water	Concentration	Example dose
10 mg lyophilized	2 mL BAC	5 mg/mL	Blend math. Confirm mg of each peptide.

Change vial size or water volume? Open the blend calculator.

Safety & Considerations

Research blend. Angiogenic theoretical risk in active cancer. Sterile technique. See the Wolverine guide for reconstitution walkthroughs.

Regulatory & Legal Status

FDA Status (US)

Research Only

BPC-157 is FDA Category 2. TB-500 is research-only. Combination is not an approved product

WADA Status (2026)

Prohibited (S0)

Competitive athletes subject to anti-doping controls should not use Wolverine Stack.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Limits of current evidence

See BPC-157 and TB-500 leaves for identity landmines.

Verdict

Wolverine is BPC-157 plus TB-500 as sold (usually Ac-LKKTETQ). Not a fracture drug. Not full-length Tβ4.

Interactions & Contraindications

Research blend. Angiogenic theoretical risk in active cancer. Sterile technique. See the Wolverine guide for reconstitution walkthroughs.

Wolverine Stack vs. GLOW Stack

Canonical comparison: Wolverine Stack vs GLOW Stack

Attribute	Wolverine Stack	GLOW Stack
Components	BPC-157 + TB-500	GHK-Cu + BPC-157 + TB-500
Job	Two-peptide recovery	Recovery plus copper-peptide skin/ECM
Evidence	Component preclinical; no blend RCT	Same - community blend
PIP	Usually milder (no GHK-Cu)	GHK-Cu sting is the rate limiter

Verdict: Wolverine is the two-peptide core. GLOW adds GHK-Cu. KLOW adds KPV on top of GLOW. Ingredient count is not evidence quality.

Frequently Asked Questions

Wolverine vs GLOW vs KLOW?▼

Wolverine = BPC + TB-500. GLOW adds GHK-Cu. KLOW adds KPV. Escalating ingredient lists, not escalating evidence.

Can I mix both in one syringe?▼

Community practice is yes for reconstitution compatibility. Dose control is easier as separate vials. Use the Blend/Stack calculator for a pre-mix.

📚 Related Articles

What Is the Wolverine Stack? BPC-157 + TB-500 Dosing, Reconstitution & Calculator Guide

12 min read • Recovery

Prescription options: compare licensed telehealth providers

Some peptide therapies are available only by prescription after a consult with a licensed clinician.

Compare telehealth →

← Back to Peptide Library